Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Comment by sunshine7on Dec 03, 2015 10:53am
116 Views
Post# 24350359

RE:RE:RE:Mackie Research

RE:RE:RE:Mackie ResearchOn Oct 26 2015 Mackie had a target of $42.50USD and spec buy rating. Adjusted earnings are expected between US$6.29 and US$6.77, the Oakville, Ontario-based company said in a statement on Monday. [that is SP ~6.5x EPS] That fell short of the $6.88 per share.average estimate of 4 analysts polled by Capital IQ. [expect CXR to beat their conservative forecast] Revenue is anticipated to be between $1.02bn and $1.06bn in fiscal 2016. That comes ahead of the Wall Street consensus of $0.88bn [this is significantly higher... revenue growth is a factor when considering multiples]
<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse